Overview

Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery

Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
0
Participant gender:
All
Summary
This is a clinical trial to evaluate the effect of intravenous iron supplement with Ferinject (Ferric Carboxymaltose) in preventing postoperative delirium after hip fracture surgery.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Collaborator:
JW Pharmaceutical
Criteria
Inclusion Criteria:

- femur neck fracture, intertrochanteric fractures

- Iron deficiency anemia (Hb<12 in women, Hb<13 in men)

- Iron deficiency (Serum ferritin <100ug/L or transferrin saturation<20%)

- Who understands this clinical trial and volunteers and agrees to this trial

Exclusion Criteria:

- Patient under the age of 65 years

- Hb<7 or someone who has acute symptom of anemia(tachycardia, dyspnea, or dizziness)

- High energy trauma

- Preoperative delirium

- MMSE<10

- Underlying disease which involves cognitive dysfunction (e.g. neurovascular diseases,
acute myocardial infarction, pulmonary embolism)

- Those who are inappropriate to participate in the clinical trial assessed by the
investigators